Arbutus Biopharma (ABUS) Equity Income (2018 - 2020)
Powered by 
Analysis
Arbutus Biopharma (ABUS) Equity Income (2018 - 2020) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 4.08 Mn |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | - |
| 10 | Arbutus Biopharma | 1.02 Bn | 923.36 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 2.50 Mn |
| Sep 30, 2020 | -2.55 Mn |
| Dec 31, 2019 | -11.03 Mn |
| Sep 30, 2019 | -3.51 Mn |
| Jun 30, 2019 | -3.33 Mn |
| Mar 31, 2019 | -4.65 Mn |
| Dec 31, 2018 | -2.72 Mn |
| Sep 30, 2018 | -2.84 Mn |